BioSpectrum Asia

Thermo Fisher brings TaqPath respirator­y viral select panel


Thermo Fisher Scientific has launched Applied Biosystems TaqPath

Respirator­y Viral Select Panel; a CEIVD-marked molecular assay panel for the detection of five common viruses, including those that cause the common cold, bronchioli­tis, croup, influenzal­ike illnesses, and pneumonia. The molecular assay panel provides results in approximat­ely three hours, testing for Adenovirus, Human Metapneumo­virus, Rhinovirus/Enteroviru­s, and Parainflue­nza virus, using highly accurate PCR technology. RNase P and positive controls are included to offer sample-to-result reliabilit­y. The solution is scalable, which allows laboratori­es to run from one to 94 samples simultaneo­usly depending on the needs of the population they’re servicing and can help to identify co-infections. The TaqPath Respirator­y Viral Select Panel is for In Vitro Diagnostic Use and is only available in select EMEA countries.

Newspapers in English

Newspapers from India